Subscribe To Our Free Newsletter |
Dr Reddy’s Labs shares surge 6.5%
Shares ofDr Reddy’s Laboratories (DRL) today surged 6.5 per cent after the company launched the generic version of Astrazeneca’s Nexium, used to treat acid reflux, in the US market.
The s...